Biosimilars — Regulatory, Health Technology Assessment, Reimbursement Trends, and Market Outlook


Project Status:
Project Line:
Health Technology Review
Project Sub Line:
Environmental Scan
Project Number:

The Environmental Scan identifies and compares information regarding the regulatory frameworks, HTA processes, and reimbursement trends of national and international organizations. It also provides a synopsis of the market outlook for biosimilars and their reference products in Canada.

The findings of this Environmental Scan are based on a literature search and correspondence with key informants from selected Health Technology Assessment organizations and with representatives from Federal, Provincial and Territorial drug plans and cancer agencies in Canada.